Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
The most recent articles from:
Ann. Allergy Asthma Immunol.
-
Ann. Allergy Asthma Immunol. · Mar 2015
Randomized Controlled TrialEffectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department.
Angiotensin-converting enzyme inhibitor-induced angioedema (ACEI-AE) is mediated by bradykinin. There remains an unmet treatment need because these patients, when presenting to the emergency department (ED), do not respond to conventional therapies, such as antihistamines and corticosteroids. ⋯ The results from this preliminary study reveal that ecallantide is safe to use and may increase the proportion of patients who meet early discharge criteria by approximately10%. A larger phase 3 study is necessary to confirm the efficacy and evaluate the cost-effectiveness of ecallantide use for ACEI-AE in the ED setting.
-
Ann. Allergy Asthma Immunol. · Dec 2014
Letter Randomized Controlled Trial Multicenter StudySublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study.